Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

JAMA: The Journal of the American Medical Association

Volumn 260, Issue 13, 1988, Pages 1917-1921

  Austin, Melissa A ^a,e   Breslow, Jan L ^b   Hennekens, Charles H ^c   Buring, Julie E ^c   Willett, Walter C ^d   Krauss, Ronald M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; CHOLESTEROL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMAN; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL; LIPOPROTEINS, LDL CHOLESTEROL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; RISK FACTORS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRIGLYCERIDES;

EID: 0023807047     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03410130125037     Document Type: Article

References (58)

1. Ross R, Harker L: Hyperlipidemia and atherosclerosis. Science 1976;193:1094-1100.
2. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial: I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-364.
3. Kannel WB, Castelli WP, Gordon T: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med 1971;74:1-12.
4. Castelli WP, Doyle JT, Gordon T, et al.: HDL cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phenotyping Study. Circulation 1977;55:767-772.
5. Miller GJ, Miller NE: Plasma high density lipoprotein concentration and development of ischemic heart disease. Lancet 1975;1:16-19.
6. Pearson TA, Bulkley BH, Achuff SC, et al.: The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol 1979;109:285-295.
7. Castelli WP, Garrison RJ, Wilson PWF, et al.: Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 1986;256:2835-2838.
8. Hulley SB, Rosenman RH, Bawol RD, et al.: Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease. N Engl J Med 1980;302:1383-1389.
9. Lippel K, Tyroler HA, Eder H, et al.: Meeting summary: Relationship of hypertriglyceridemia to atherosclerosis. Arteriosclerosis 1981;1:406-417.
10. Heiss G, Tyroler HA: Are apolipoproteins useful for evaluating ischemic heart disease? A brief overview of the literature, in Lippel K (ed): Proceedings of the Workshop on Apolipoprotein Quantification, publication 83-1266. Bethesda, Md, National Institutes of Health, 1983, pp 7-229.
11. Brunzell JD, Sniderman AD, Albers JJ, et al.: Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis 1984;4:79-83.
12. Krauss RM, Lindgren FT, Williams PT, et al.: Intermediate density lipoproteins and coronary artery disease progression in hypercholesterolemic men. Lancet 1987;2:62-66.
13. Shen MMS, Krauss RM, Lindgren FT, et al.: Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res 1981;22:236-244.
14. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982;23:97-104.
15. Fisher WR, Hammond MG, Warmke GL: Measurements of the molecular weight variability of plasma low density lipoproteins among normals and subjects with hyperbetalipoproteinemia: Demonstration of macromolecular heterogeneity. Biochemistry 1972;11:519-525.
16. Austin MA, Krauss RM: Genetic control of low density lipoprotein subclasses. Lancet 1986;2:592-595.
17. Crouse JR, Parks JS, Schey HM: Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 1985;26:566-574.
18. Fisher WR: Heterogeneity of plasma low density lipoproteins manifestations of the physiologic phenomenon in man. Metabolism 1983;32:283-291.
19. Hennekens CH, Buring JE, O’Conner GT, et al.: Moderate alcohol consumption and risk of myocardial infarction. Circulation 1987;76(suppl 4):501.
20. The prevalence study, in Lipid Research Clinics Population Studies Data Book, publication 80-1527. Bethesda, Md, National Institutes of Health, 1980, vol 1, pp 28-81.
21. Warnick GR, Benderson J, Albers JJ: Dextran sulfate-Mg2+ precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin Chem 1982;28:1379-1388.
22. Lipid Research Clinics Program: Manual of Laboratory Operations: Lipid and Lipoprotein Analysis, DHEW publication (NIH) 75-628. Bethesda, Md, National Institutes of Health, 1975, vol 1,pp 51-59.
23. Eisenberg S, Gavish D, Oschry Y, et al.: Abnormalities in very low, low, and high density lipoproteins in hypertriglyceridemia: Reversal toward normal with Bezafibrate treatment. J Clin Invest 1984;74:470-482.
24. Lindgren FT, Jensen LC, Hatch FT: The isolation and quantitative analysis of serum lipoproteins, in Nelson GJ (ed): Blood Lipids and Lipoproteins. New York, John Wiley & Sons Inc, 1972, pp 181-274.
25. Winer BJ: Statistical Principles in Experimental Design, ed 2. New York, McGraw-Hill International Book Co, 1971.
26. Fleiss JL: Statistical Methods for Rates and Proportions, ed 2. New York, John Wiley & Sons Inc, 1981.
27. Kleinbaum DG, Kupper LL: Applied Regression Analysis and Other Multivariate Methods. Boston, Duxbury Press, 1978.
28. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research. Belmont, Calif, Lifetime Learning Publications, 1982, pp 403-456.
29. Schlesselman JJ: Case-Control Studies: Design, Conduct, Analysis. New York, Oxford University Press, 1982.
30. Breslow NE, Day NE: The analysis of casecontrol studies, in Statistical Methods in Cancer Research, publication 32. Lyons, France, International Agency for Research on Cancer, vol 1, 1980.
31. Basics, in SAS Users Guide, ed 5. Cary, NC, SAS Institute Inc, 1985.
32. Statistics, in SAS Users Guide, ed 5. Cary, NC, SAS Institute Inc, 1985.
33. Krauss RM, Lindgren FT, Ray RM: Interrelationships among subgroups of serum lipoproteins in normal human subjects. Clin Chim Acta- 1980; 104:275-290.
34. McNamara J, Campos H, Ordovas JM, et al.: The effect of gender, age, and lipid status on low density lipoprotein subfraction distributions: Results from the Framingham Offspring Study. Arteriosclerosis 1987;7:483-490.
35. Teng B, Thompson GR, Sniderman AD, et al.: Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc Natl Acad Sci USA 1983;80:6662-6666.
36. Krauss RM: Relationship of intermediate and low density lipoprotein subspecies to risk of coronary artery disease. Am Heart J 1987;113:578-582.
37. Sniderman A, Shapiro S, Marpole D, et al.: Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density [β] lipoproteins). Proc Natl Acad Sci USA 1980;77:604-608.
38. Austin MA, King M-C, Vranizan KM, et al.: Inheritance of low density lipoprotein subclass patterns: Results of complex segregation analysis. Am J Hum Genet, in press.
39. Priestly L, Knott T, Wallis S, et al.: RFLP for the human apolipoprotein B gene. Nucl Acid Res 1985;13:6789-6793.
40. Huang L-S, Miller DA, Bruns GAP, et al.: Mapping of the human apoB gene to chromosome 2p and demonstration of a two-allele restriction fragment length polymorphism. Proc Natl Acad Sci USA 1986;83:644-648.
41. Law A, Wallis SC, Powell LM, et al.: Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1986;1:1301-1303.
42. Hegele RA, Huang L-S, Herbert PN, et al.: Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 1986;315:1509-1515.
43. Micheli H, Pometta D, Jarnot C, et al.: High density lipoprotein cholesterol in male relatives of patients with coronary heart disease. Atherosclerosis 1979;32:264-276.
44. Vergani C, Bettale G: Familial hypoalphalipoproteinemia. Clin Chim Acta 1981;114:45-52.
45. Third JHC, Montag J, Glynn M, et al.: Primary and familial hypoalphalipoproteinemia. Metabolism 1984;33:136-146.
46. Byard PJ, Borecki IB, Glueck CJ, et al.: A genetic study of hypoalphalipoproteinemia. Genet Epidemiol 1984;1:43-51.
47. Lalouel JM, Rao DC, Morton NE, et al.: A unified model for complex segregation analysis. Am J Hum Genet 1983;35:816-826.
48. Iselius L, Carlson LA, Morton NE, et al.: Genetic and environmental determinants for lipoprotein concentrations in blood. Acta Med Scand 1985;217:161-170.
49. Goldstein JL, Schrott HG, Hazzard WR, et al.: Hyperlipidemia in coronary heart disease: II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973;52:1544-1568.
50. Brunzell JD, Albers JJ, Chait A, et al.: Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 1983;24:147-155.
51. Kissebah AH, Alfarsi S, Evans DJ: Low density lipoprotein metabolism in familial combined hyperlipidemia: Mechanism of the multiple lipoprotein phenotypic expression. Arteriosclerosis 1984;4:614-624.
52. Krauss RM, Albers JJ, Brunzell JD: An apolipoprotein B-enriched low density lipoprotein subspecies in familial combined hyperlipidemia. Clin Res 1983;31:503a.
53. Schaefer EJ, McNamara JR, Genest J, et al.: LDL particle size, lipoproteins, and apolipoproteins in premature coronary artery disease (CAD): Confounding effects beta blockers. Circulation 1987;76(suppl 4):531.
54. Rohlfing JJ, Brunzell JD: The effects of diuretics and adrenergic-blocking agents on plasma lipids. West J Med 1986;145:210-218.
55. Ernst N, Fisher M, Smith W, et al.: The association of plasma high density lipoprotein cholesterol with dietary intake and alcohol consumption: The Lipid Research Clinics Prevalence Study. Circulation 1980;62(suppl 4):41-52.
56. Heiss G, Johnson NJ, Reiland S, et al.: The epidemiology of plasma high density lipoprotein cholesterol levels: The Lipid Research Clinics Program Prevalence Study: Summary. Circulation 1980;62:116-136.
57. Haskell WL, Taylor HL, Wood PD, et al.: Strenuous physical activity treadmill exercise test performance and plasma high density lipoprotein cholesterol: The Lipid Research Clinics Prevalence Study. Circulation 1980;62(suppl 4):53-61.
58. Grundy SM: Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986;314:745-748.